HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT FOR SELECT ONCOLOGY THERAPIES IN EUROPEAN MAJOR MARKETS

被引：0

作者：

Koka, N. S. ^{[1
]}

Syed, A. A. ^{[1
]}

Ahmad, M. ^{[1
]}

Patel, K. ^{[1
]}

Nair, S. ^{[1
]}

Shah, S. ^{[1
]}

机构：

[1] Market Access Solut LLC LTD MKTXS, Raritan, NJ USA

来源：

VALUE IN HEALTH | 2022年 / 25卷 / 12期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

HTA169

引用

页码：S329 / S329

页数：1

共 50 条

[21] Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
Elvira, David
Obach, Merce
Pontes, Caridad
BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
[22] Health Technology Assessment and Health Care Reimbursement in the European Union: Permissive Dissensus and the Limits of Harmonization through the Backdoor
Loblova, Olga
JOURNAL OF HEALTH POLITICS POLICY AND LAW, 2021, 46 (01) : 117 - 145
[23] Reimbursement of biosimilars in Poland: is there a link to health technology assessment?
Neumann, Dominika
Jablecka, Anna
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 781 - 792
[24] Health Technology Assessment: At the Junction of Evidence, Policy, and Reimbursement
Standaert, Christopher J.
PM&R, 2015, 7 (02) : 203 - 205
[25] Technology assessment of digital health applications for reimbursement decisions
Jeindl, Reinhard
Wild, Claudia
WIENER MEDIZINISCHE WOCHENSCHRIFT, 2024, 174 (3-4) : 44 - 52
[26] AGENCY AGREEMENT IN HEALTH TECHNOLOGY ASSESSMENT REIMBURSEMENT DECISIONS
Jaksa, A.
Demb, J.
Ho, Y. S.
Daniel, K.
VALUE IN HEALTH, 2013, 16 (03) : A3 - A3
[27] Variation in Health Technology Assessment and Reimbursement Processes in Europe
Akehurst, Ronald L.
Abadie, Eric
Renaudin, Noel
Sarkozy, Francois
VALUE IN HEALTH, 2017, 20 (01) : 67 - 76
[28] INTERNATIONAL COMPARISONS OF HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT OUTCOMES FOR ONCOLOGY DRUGS WITH REGULATORY REVIEW THROUGH PROJECT ORBIS
Beca, J.
Scott, K.
Gosselin, S.
Ajrawat, P.
Thon, J.
Lee, S. M.
VALUE IN HEALTH, 2023, 26 (06) : S238 - S238
[29] ECONOMIC EVALUATIONS OF SUBCUTANEOUSLY ADMINISTERED ONCOLOGY THERAPIES: A HEALTH TECHNOLOGY ASSESSMENT (HTA) LANDSCAPE REVIEW
Wu, E.
Schenkel, B.
Povsic, M.
Wyn, R.
Hernani, M.
Kornalska, K.
VALUE IN HEALTH, 2019, 22 : S77 - S77
[30] HEALTH OUTCOMES AND ECONOMICS RESEARCH FOR CELLULAR THERAPIES AND REGENERATIVE MEDICINES: LESSONS FROM A HEALTH TECHNOLOGY ASSESSMENT AND REIMBURSEMENT ANALYSIS IN THE UNITED STATES
Faulkner, E. C.
Spinner, D. S.
VALUE IN HEALTH, 2011, 14 (03) : A23 - A23

← 1 2 3 4 5 →